These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 5676807)

  • 1. Propranolol hydrochloride (inderal).
    Clin Pharmacol Ther; 1968; 9(5):696-703. PubMed ID: 5676807
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism of propranolol ('Inderal'), a potent, specific beta-adrenergic receptor blocking agent.
    Bond PA
    Nature; 1967 Feb; 213(5077):721. PubMed ID: 6031788
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetic and pharmacodynamic studies with a new controlled-release formulation of propranolol in normal volunteers: a comparison with other commercially available formulations.
    Perucca E; Grimaldi R; Gatti G; Caravaggi M; Crema F; Lecchini S; Frigo GM
    Br J Clin Pharmacol; 1984 Jul; 18(1):37-43. PubMed ID: 6743489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological actions of 1-(o-methoxyphenoxy)3-isopropylamino-2-propanol hydrochloride (S-D-1601), a new beta-blocking agent.
    Ferrini R; Miragoli G; Croce G
    Arzneimittelforschung; 1970 Aug; 20(8):1074-9. PubMed ID: 4394830
    [No Abstract]   [Full Text] [Related]  

  • 5. An evaluation of once daily long acting propranolol hydrochloride (Inderal LA and Half-Inderal LA) in the treatment of anxiety. A double-blind placebo-controlled general practice study.
    Hudson CF
    Br J Clin Pract; 1988 Oct; 42(10):419-26. PubMed ID: 3076469
    [No Abstract]   [Full Text] [Related]  

  • 6. The pharmacology of "inderal" (propranolol hydrochloride).
    Barrett AM
    Brux Med; 1970 Sep; 50(9):577-82. PubMed ID: 5510356
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl) thiazole hydrochloride (S-596), a new beta-adrenergic blocking agent (author's transl)].
    Hara Y; Sato E; Miyagishi A; Aono S; Nakatani H
    Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):707-20. PubMed ID: 94296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theoretical Michaelis-Menten elimination model for propranolol.
    McAinsh J; Gay MA
    Eur J Drug Metab Pharmacokinet; 1985; 10(3):241-5. PubMed ID: 4085525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronopharmacology of strophanthin and inderal: an experimental study.
    Aslanian NL; Samvelian VM; Gasparian GS
    Cor Vasa; 1990; 32(5):421-31. PubMed ID: 2286091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro detection of possible in vivo drug interactions. Part 1. The effect of hydrochlorothiazide and frusemide on the in vitro absorption characteristics of propranolol hydrochloride.
    Anber SA; Al-Janabi II; Mustafa RM; Razzo FN
    Pharmazie; 1981 Jun; 36(6):425-7. PubMed ID: 7279990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avoidance of first pass elimination of propranolol after rectal administration to rats.
    de Boer AG; Gubbens-Stibbe JM; Breimer DD
    J Pharm Pharmacol; 1981 Jan; 33(1):50-1. PubMed ID: 6114157
    [No Abstract]   [Full Text] [Related]  

  • 12. Human bioavailability of propranolol from a matrix-in-cylinder system with a HPMC-Gelucire core.
    Mehuys E; Remon JP; Korst A; Van Bortel L; Mols R; Augustijns P; Porter C; Vervaet C
    J Control Release; 2005 Oct; 107(3):523-36. PubMed ID: 16055224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some inhibitory actions of catecholamines and their blockade by propranolol.
    Singh KP; Mahawar MM
    Arch Int Pharmacodyn Ther; 1968 Jan; 171(1):58-67. PubMed ID: 5689546
    [No Abstract]   [Full Text] [Related]  

  • 14. Propranolol absorption in different regions of the rat gastrointestinal tract in situ: implications for sustained release formulations.
    Taylor DC; Grundy R
    J Pharm Pharmacol; 1980 Jul; 32(7):499-500. PubMed ID: 6105188
    [No Abstract]   [Full Text] [Related]  

  • 15. General pharmacological profiles of the new beta-adrenoceptor antagonist carvedilol.
    Hirohashi M; Takasuna K; Tamura K; Yamaguchi K; Maekawa K; Yamada S; Iwasaki S; Yoshida M; Nomura M; Taguchi K
    Arzneimittelforschung; 1990 Jul; 40(7):735-46. PubMed ID: 1977393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of ketamine and propranolol on plasma renin activity (PRA) in female rabbits and guinea pigs.
    Kalenga MK; De Hertogh R; Vankrieken L; Thomas K
    J Physiol (Paris); 1991; 85(4):195-8. PubMed ID: 1820453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol.
    Fitzgerald JD; O'Donnell SR
    Br J Pharmacol; 1971 Sep; 43(1):222-35. PubMed ID: 4400184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption of practolol and propranolol in dog intestinal loops in situ [proceedings].
    Taylor DC; Grundy RU; Loveday BE
    J Pharm Pharmacol; 1977 Dec; 29 Suppl():51P. PubMed ID: 22683
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of Inderal on certain hemodynamic indices in arterial hypertension].
    Kocemba J; Dubiel J; Gabryś B
    Pol Tyg Lek; 1970 Aug; 25(34):1280-2. PubMed ID: 5507157
    [No Abstract]   [Full Text] [Related]  

  • 20. A simple method for recording the electrocardiogram and heart rate from conscious animals.
    Farmer JB; Levy GP
    Br J Pharmacol Chemother; 1968 Jan; 32(1):193-200. PubMed ID: 5640172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.